KARL STORZ United States is proud to announce that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for the AventaMed Solo+â„¢ Tympanostomy Tube Device (TTD), allowing its use in pediatric patients aged 6 months and older. This expanded...
READ MORE




